Study: Metformin may not improve survival rates after breast cancer

[News]

Despite previous scientific studies that suggest diabetes drug metformin has anti-cancer properties, a new, first-of-its-kind study from Women's College Hospital has found the drug may not actually improve survival rates after breast cancer in certain patients.

More... (http://www.news-medical.net/news/20130510/Study-Metformin-may-not-improve-survival-rates-after-breast-cancer.aspx)